{{Rsnum
|rsid=2118674
|Gene=MYO3B
|Chromosome=2
|position=170462384
|Orientation=plus
|GMAF=0.1612
|Gene_s=MYO3B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 8.0 | 92.0
| HCB | 10.2 | 35.0 | 54.7
| JPT | 2.7 | 31.9 | 65.5
| YRI | 15.1 | 47.9 | 37.0
| ASW | 8.8 | 40.4 | 50.9
| CHB | 10.2 | 35.0 | 54.7
| CHD | 9.2 | 42.2 | 48.6
| GIH | 1.0 | 8.9 | 90.1
| LWK | 14.2 | 38.7 | 47.2
| MEX | 0.0 | 5.2 | 94.8
| MKK | 2.6 | 33.1 | 64.3
| TSI | 1.0 | 7.8 | 91.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23362303
  |Trait=Palmitoleic acid (16:1n-7) plasma levels
  |Title=Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
  |RiskAllele=A
  |Pval=4E-7
  |OR=.05
  |ORtxt=unit decrease
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}